Literature DB >> 31926274

Piceatannol: A natural stilbene for the prevention and treatment of cancer.

Kishore Banik1, Abhishek Manoj Ranaware2, Choudhary Harsha1, Thakur Nitesh1, Sosmitha Girisa1, Vishwas Deshpande2, Lu Fan3, Savita Pravin Nalawade2, Gautam Sethi4, Ajaikumar B Kunnumakkara5.   

Abstract

The World Health Organization (WHO) has documented that cancer is the second foremost reason for death worldwide. Various factors are responsible for cancer, for instance, exposure to different physical, chemical and biological carcinogens, infections, hereditary, poor dietary habits and lifestyle etc. Cancer is a preventable disease if detected at an early stage; however, most of the cases of cancer are diagnosed at an incurable advanced or metastatic stage. According to WHO about 70 % of deaths due to cancer occur in countries with low- or middle-income. The major problems associated with the conventional therapies are cancer recurrence, development of chemoresistance, affordability, late-stage diagnosis, adverse side effects and inaccessible treatment. Thus, there is an urgent need to find alternative treatment modalities, which have easy accessibility and are affordable with minimum side effects. In this article, we reviewed the natural stilbene known as "Piceatannol" for its anticancer properties. Numerous preclinical studies have reported the potential of Piceatannol to prevent or impede the growth of various cancers originating from different organs such as brain, breast, cervical, colon, liver, lung, prostate, skin, etc. The current review primarily emphasises on the insights of Piceatannol source, chemistry, and the molecular mechanisms involved in the regression of the tumor. This review supports Piceatannol as a potential anticancer and chemopreventive agent and suggests that it can be effectively employed as a capable anti-cancer drug.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; Chemoprevention; Molecular targets; Natural product; Piceatannol; Stilbene

Mesh:

Substances:

Year:  2020        PMID: 31926274     DOI: 10.1016/j.phrs.2020.104635

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  32 in total

1.  Piceatannol alleviates glucolipotoxicity induced vascular barrier injury through inhibition of the ROS/NF-kappa B signaling pathway.

Authors:  Zhen Wang; Yun-Long Lu; Miao Chen; Hong-Fei Xu; Liang-Rong Zheng
Journal:  Am J Transl Res       Date:  2022-01-15       Impact factor: 4.060

2.  Effect of piceatannol against malignant melanoma in vivo and in vitro.

Authors:  Bo Yu; Wei Liu; Min-Qi Hu; Xiu-Fa Tang; Chun-Jie Li; Lin Que
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2021-08-01

Review 3.  The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer.

Authors:  Elina Khatoon; Mangala Hegde; Aviral Kumar; Uzini Devi Daimary; Gautam Sethi; Anupam Bishyaee; Ajaikumar B Kunnumakkara
Journal:  Arch Pharm Res       Date:  2022-08-20       Impact factor: 6.010

4.  Exploring the Cytotoxic Effects of the Extracts and Bioactive Triterpenoids from Dillenia indica against Oral Squamous Cell Carcinoma: A Scientific Interpretation and Validation of Indigenous Knowledge.

Authors:  Maniyamma Aswathy; Kishore Banik; Dey Parama; Parameswaran Sasikumar; Choudhary Harsha; Anuja Gracy Joseph; Daisy R Sherin; Manojkumar K Thanathu; Ajaikumar B Kunnumakkara; Radhakrishnan Kokkuvayil Vasu
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-09

Review 5.  From Simple Mouth Cavities to Complex Oral Mucosal Disorders-Curcuminoids as a Promising Therapeutic Approach.

Authors:  Sosmitha Girisa; Aviral Kumar; Varsha Rana; Dey Parama; Uzini Devi Daimary; Saman Warnakulasuriya; Alan Prem Kumar; Ajaikumar B Kunnumakkara
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-17

Review 6.  COVID-19, cytokines, inflammation, and spices: How are they related?

Authors:  Ajaikumar B Kunnumakkara; Varsha Rana; Dey Parama; Kishore Banik; Sosmitha Girisa; Sahu Henamayee; Krishan Kumar Thakur; Uma Dutta; Prachi Garodia; Subash C Gupta; Bharat B Aggarwal
Journal:  Life Sci       Date:  2021-02-16       Impact factor: 5.037

7.  Solute carrier family 12 member 8 impacts the biological behaviors of breast carcinoma cells by activating TLR/NLR signaling pathway.

Authors:  LinWei Li; Jing Xia; RuTing Cui; Bin Kong
Journal:  Cytotechnology       Date:  2020-11-11       Impact factor: 2.058

Review 8.  Nobiletin in Cancer Therapy: How This Plant Derived-Natural Compound Targets Various Oncogene and Onco-Suppressor Pathways.

Authors:  Milad Ashrafizadeh; Ali Zarrabi; Sedigheh Saberifar; Farid Hashemi; Kiavash Hushmandi; Fardin Hashemi; Ebrahim Rahmani Moghadam; Reza Mohammadinejad; Masoud Najafi; Manoj Garg
Journal:  Biomedicines       Date:  2020-05-05

Review 9.  Therapeutic Emergence of Rhein as a Potential Anticancer Drug: A Review of Its Molecular Targets and Anticancer Properties.

Authors:  Sahu Henamayee; Kishore Banik; Bethsebie Lalduhsaki Sailo; Bano Shabnam; Choudhary Harsha; Satti Srilakshmi; Naidu Vgm; Seung Ho Baek; Kwang Seok Ahn; Ajaikumar B Kunnumakkara
Journal:  Molecules       Date:  2020-05-12       Impact factor: 4.411

Review 10.  Phytochemicals Targeting JAK-STAT Pathways in Inflammatory Bowel Disease: Insights from Animal Models.

Authors:  Sun Young Moon; Kwang Dong Kim; Jiyun Yoo; Jeong-Hyung Lee; Cheol Hwangbo
Journal:  Molecules       Date:  2021-05-10       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.